Biocentury: Singapore’s next challenge: turning momentum into sustainable growth

Published on : 14th February 2024

Read about the key role of 65LAB in Singapore’s burgeoning ecosystem, as it seeks to advance academic projects through the steps towards company formation.

65LAB and Duke-NUS award US$1.85 million to combat chronic inflammation

Recipient Associate Professor Lena Ho spearheads groundbreaking research to develop first-in-class therapeutics to target inflammatory diseases Collaboration between 65LAB and Duke-NUS aims to advance

Evotec’s White Paper Series: From Academic Concept to Commercial Reality: How to Accelerate Translational Drug Discovery

Discover more about the way-markers for a successful translational roadmap from the investor’s perspective Discover more from Evotec

Drug Discovery World Winter issue 2023/ 2024

Read DDW’s insights into whether AI can deliver better immunotherapies for cancer, and predictions on what to expect from the sector in 2024 Read